The first GlaxoSmithKline (GSK)-Duke Statistics Workshop on Critical Statistical Issues in Drug Development was held October 29, 2013, at the GSK Research Triangle Park location. It was well attended, with more than 100 participants from both Duke and GSK.
clinical
The Statistician’s Role in an Integrated Health Care System
The need to improve the effectiveness of clinical care delivery is greater than ever. Here, Intermountain Healthcare clinicians Karen Valentine, Roberta James, and Cempaka Martial discuss a statistician’s role in an integrated health care system.
Biostatistics on the Rise in Japan
Japan is second only to the United States as a consumer of pharmaceutical products. This notwithstanding, statistical contributions to clinical trials and clinical development were not well-recognized in Japan until the ICH-E9 guideline “Statistical Principles for Clinical Trials” was implemented in 1998.



